AU2002230836A1 - Benzylamine derivatives and their use as thrombin inhibitors - Google Patents
Benzylamine derivatives and their use as thrombin inhibitorsInfo
- Publication number
- AU2002230836A1 AU2002230836A1 AU2002230836A AU3083602A AU2002230836A1 AU 2002230836 A1 AU2002230836 A1 AU 2002230836A1 AU 2002230836 A AU2002230836 A AU 2002230836A AU 3083602 A AU3083602 A AU 3083602A AU 2002230836 A1 AU2002230836 A1 AU 2002230836A1
- Authority
- AU
- Australia
- Prior art keywords
- thrombin inhibitors
- benzylamine derivatives
- benzylamine
- derivatives
- thrombin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25630400P | 2000-12-18 | 2000-12-18 | |
US60256304 | 2000-12-18 | ||
US32318401P | 2001-09-18 | 2001-09-18 | |
US60323184 | 2001-09-18 | ||
PCT/US2001/048321 WO2002050056A1 (en) | 2000-12-18 | 2001-12-14 | Benzylamine derivatives and their use as thrombin inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002230836A1 true AU2002230836A1 (en) | 2002-07-01 |
Family
ID=26945268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002230836A Abandoned AU2002230836A1 (en) | 2000-12-18 | 2001-12-14 | Benzylamine derivatives and their use as thrombin inhibitors |
Country Status (6)
Country | Link |
---|---|
US (1) | US6515011B2 (en) |
JP (1) | JP2004516286A (en) |
AU (1) | AU2002230836A1 (en) |
CA (1) | CA2431588A1 (en) |
PE (1) | PE20020759A1 (en) |
WO (1) | WO2002050056A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6528503B2 (en) | 2000-12-18 | 2003-03-04 | Merck & Co., Inc. | Thrombin inhibitors |
JP2005504003A (en) | 2001-02-09 | 2005-02-10 | メルク エンド カムパニー インコーポレーテッド | Thrombin inhibitor |
DK1485345T3 (en) | 2002-03-11 | 2008-11-03 | Curacyte Ag | Urokinase Inhibitors, Their Preparation and Use |
DE10301300B4 (en) | 2003-01-15 | 2009-07-16 | Curacyte Chemistry Gmbh | Use of acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |
DE10342108A1 (en) | 2003-09-11 | 2005-04-14 | Curacyte Chemistry Gmbh | Basic substituted benzylamine analogs as coagulation factor Xa inhibitors, their preparation and use |
JP4606041B2 (en) * | 2004-03-05 | 2011-01-05 | セントラル硝子株式会社 | Optically active 1-aryl-2-fluoro-substituted ethylamines and process for producing the same |
DE102005044319A1 (en) * | 2005-09-16 | 2007-03-22 | Curacyte Chemistry Gmbh | 2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa |
DE102006050672A1 (en) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations |
JP4910148B2 (en) * | 2007-03-09 | 2012-04-04 | 国立大学法人 名古屋工業大学 | Method for producing optically active α-fluorobis (phenylsulfonyl) methyl adduct and method for producing optically active α-fluoromethylamine derivative |
TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
EA018502B1 (en) * | 2008-06-23 | 2013-08-30 | Астразенека Аб | New heterocyclic carboxamides and pharmaceutical compositions containing them |
EP2230231A1 (en) * | 2009-03-16 | 2010-09-22 | Bayer CropScience AG | Method for manufacturing 2,2-difluoroethylamine derivatives by imine hydrogenation |
US8828474B2 (en) * | 2009-09-20 | 2014-09-09 | Medtronic Vascular, Inc. | Apparatus and methods for loading a drug eluting medical device |
AU2011349022B2 (en) | 2010-12-21 | 2017-04-13 | The Medicines Company (Leipzig) Gmbh | Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa |
WO2014025658A1 (en) * | 2012-08-08 | 2014-02-13 | Merck Sharp & Dohme Corp. | Pyrrolidine thrombin inhibitors |
US9469608B2 (en) | 2012-11-20 | 2016-10-18 | Merck Sharp & Dohme Corp. | Thrombin inhibitors |
CN103641769B (en) * | 2013-12-06 | 2015-11-04 | 爱斯特(成都)生物制药有限公司 | The preparation method of isoindoline hydrochloride |
GB201805174D0 (en) * | 2018-03-29 | 2018-05-16 | Univ Leeds Innovations Ltd | Compounds |
EP3802489A4 (en) * | 2018-05-29 | 2022-04-13 | Omeros Corporation | Masp-2 inhibitors and methods of use |
US11584714B2 (en) | 2018-05-29 | 2023-02-21 | Omeros Corporation | MASP-2 inhibitors and methods of use |
CN115052862A (en) | 2019-12-04 | 2022-09-13 | 奥默罗斯公司 | MASP-2 inhibitors and methods of use |
JP2023504543A (en) | 2019-12-04 | 2023-02-03 | オメロス コーポレーション | MASP-2 inhibitors and methods of use |
GB202107722D0 (en) | 2021-05-28 | 2021-07-14 | Lunac Therapeutics Ltd | Factor XIIA Inhibitors |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB532958A (en) | 1939-08-03 | 1941-02-04 | Humphrey Desmond Murray | Improvements in or relating to light-sensitive diazo compounds |
HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
IE58849B1 (en) | 1984-12-18 | 1993-11-17 | Gruenenthal Chemie | Use of dipeptide derivatives for the manufacture of medicaments for the treatment of patients with amyotrophic lateral sclerosis |
HU192646B (en) | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
IL77748A (en) | 1985-02-04 | 1991-11-21 | Merrell Dow Pharma | Amino acid and peptide derivatives as peptidase inhibitors |
US4804743A (en) | 1987-01-29 | 1989-02-14 | Warner-Lambert Copmany | Proline-containing renin inhibitors |
ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
US5332726A (en) | 1989-09-29 | 1994-07-26 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic peptides and pseudopeptides |
GB9017694D0 (en) | 1990-08-13 | 1990-09-26 | Sandoz Ltd | Improvements in or relating to organic chemistry |
IL99527A (en) | 1990-09-28 | 1997-08-14 | Lilly Co Eli | Tripeptide antithrombotic agents |
GB9024129D0 (en) | 1990-11-06 | 1990-12-19 | Thrombosis Research Trust | Inhibitors and substrates of thrombin |
US5688768A (en) | 1991-02-19 | 1997-11-18 | Cor Therapeutics, Inc. | Recombinant thrombin receptor and related pharmaceuticals |
CA2075154A1 (en) | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
US5252566A (en) | 1991-11-12 | 1993-10-12 | Eli Lilly And Company | Antithrombotic agents |
US5416093A (en) | 1991-11-12 | 1995-05-16 | Eli Lilly And Company | Antithrombotic agents |
AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
DE4242655A1 (en) | 1992-12-17 | 1994-06-23 | Behringwerke Ag | Use of thrombin inhibitors to inhibit ocular fibrin formation |
SE9301916D0 (en) | 1993-06-03 | 1993-06-03 | Ab Astra | NEW PEPTIDES DERIVATIVES |
EP0648780A1 (en) | 1993-08-26 | 1995-04-19 | Bristol-Myers Squibb Company | Heterocyclic thrombin inhibitors |
ZA951617B (en) | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
US5691356A (en) * | 1994-03-21 | 1997-11-25 | Bristol-Myers Squibb Company | Disubstituted heterocyclic thrombin inhibitors |
US5510369A (en) | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
CA2216859A1 (en) | 1995-04-04 | 1996-10-10 | Merck & Co., Inc. | Thrombin inhibitors |
US5629324A (en) | 1995-04-10 | 1997-05-13 | Merck & Co., Inc. | Thrombin inhibitors |
WO1997015190A1 (en) * | 1995-10-24 | 1997-05-01 | Merck & Co., Inc. | Thrombin inhibitors |
US5798377A (en) | 1996-10-21 | 1998-08-25 | Merck & Co., Inc. | Thrombin inhibitors |
US5869487A (en) | 1996-10-24 | 1999-02-09 | Merck & Co., Inc. | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
US6017934A (en) | 1997-01-22 | 2000-01-25 | Merck & Co., Inc. | Thrombin inhibitors |
US5792779A (en) | 1997-02-19 | 1998-08-11 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US5866573A (en) | 1997-04-21 | 1999-02-02 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
US6011038A (en) | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
US6087373A (en) | 1997-09-23 | 2000-07-11 | Merck & Co., Inc. | Thrombin inhibitors |
US6004976A (en) | 1997-12-01 | 1999-12-21 | Merck & Co., Inc. | Thrombin inhibitors |
SE9704543D0 (en) * | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
US6147078A (en) | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
SE9804313D0 (en) * | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
US6239132B1 (en) | 1999-04-23 | 2001-05-29 | Merck & Co., Inc. | Thrombin inhibitors |
UA58636C2 (en) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Pyrazinone thrombin inhibitors, pharmaceutical composition, method for treatment conditions caused by thrombus formation |
WO2001038323A1 (en) | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
AU2001278997A1 (en) | 2000-07-28 | 2002-02-13 | Merck And Co., Inc. | Thrombin inhibitors |
-
2001
- 2001-12-14 CA CA002431588A patent/CA2431588A1/en not_active Abandoned
- 2001-12-14 JP JP2002551552A patent/JP2004516286A/en not_active Withdrawn
- 2001-12-14 AU AU2002230836A patent/AU2002230836A1/en not_active Abandoned
- 2001-12-14 WO PCT/US2001/048321 patent/WO2002050056A1/en not_active Application Discontinuation
- 2001-12-18 PE PE2001001264A patent/PE20020759A1/en not_active Application Discontinuation
- 2001-12-18 US US10/023,776 patent/US6515011B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2004516286A (en) | 2004-06-03 |
WO2002050056A1 (en) | 2002-06-27 |
PE20020759A1 (en) | 2002-08-22 |
US20020119992A1 (en) | 2002-08-29 |
US6515011B2 (en) | 2003-02-04 |
CA2431588A1 (en) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002230836A1 (en) | Benzylamine derivatives and their use as thrombin inhibitors | |
AU2001249969A1 (en) | Inha inhibitors and their use as antibacterials | |
IL156096A0 (en) | New mandelic acid derivatives and their use as thrombin inhibitors | |
AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
HK1053124A1 (en) | Substituted quinazoline derivatives and their use as inhibitors | |
AU2001244355A1 (en) | Heterobiarylsulphonamides and their use as pde 7 inhibitors | |
AU2002356762A1 (en) | 4-arylquinazolines and use thereof as nhe-3 inhibitors | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU2001270260A1 (en) | 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors | |
AU2002361861A1 (en) | SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF | |
AU2003232848A1 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
AU2001294557A1 (en) | Thrombin inhibitors | |
PL349769A1 (en) | New amidinobenzylamine derivatives and their use as thrombin inhibitors | |
AU2002216649A1 (en) | Benzoxazole lpaat- beta inhibitors and uses thereof | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
IL152396A0 (en) | New thiochromane derivatives derivatives and their use as thrombin inhibitors | |
AU2002337913A1 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
AU2001276027A1 (en) | Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors | |
AU2002216650A1 (en) | Triazine derivatives as lpaat-b inhibitors and uses thereof | |
AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
AU2002223313A1 (en) | Protease inhibitors and their pharmaceutical uses | |
AU2001232809A1 (en) | Gyrase inhibitors and uses thereof | |
AU2001277561A1 (en) | Biphenyl derivatives and the use thereof as integrin inhibitors | |
AU2001255408A1 (en) | Tetrahydro-azepinone derivatives as thrombin inhibitors | |
AU2001266124A1 (en) | 2-aminothiazoline derivatives and their use as no-synthase inhibitors |